Northwest Biotherapeutics (NWBO) Current Leases (2019 - 2026)
Northwest Biotherapeutics (NWBO) posted quarterly Current Leases of $274000.0 for Q1 2026, down 29.74% year-over-year from $390000.0 in Q1 2025, and down 26.74% quarter-over-quarter from $374000.0 in Q4 2025.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Current Leases (2019 - 2026) Analysis & Trends
Northwest Biotherapeutics' Current Leases history runs 8 years deep, the most recent figure standing at $274000.0 for Q1 2026.
- In Q1 2026, Current Leases fell 29.74% year-over-year to $274000.0; the TTM figure through Mar 2026 stood at $274000.0 (down 29.74% YoY), while the FY2025 annual figure was $374000.0, up 14.72% from the prior year.
- Current Leases for Q1 2026 stood at $274000.0, down from $374000.0 in the prior quarter.
- The five-year high for Current Leases was $448000.0 in Q2 2025, with the low at $175000.0 in Q2 2024.
- The 5-year median for Current Leases is $334000.0 (2022), against an average of $333294.1.
- The sharpest annual moves came in 2024 and 2025: Current Leases plunged 54.55% in 2024, then surged 156.0% in 2025.
- Northwest Biotherapeutics' Current Leases stood at $354000.0 in 2022, then slipped by 11.3% to $314000.0 in 2023, then advanced by 3.82% to $326000.0 in 2024, then rose by 14.72% to $374000.0 in 2025, then decreased by 26.74% to $274000.0 in 2026.
- Business Quant data shows NWBO's Current Leases at $274000.0 in Q1 2026, $374000.0 in Q4 2025, and $399000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Northwest Biotherapeutics | 278.23 Mn | 277.63 Mn | - | 212,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 212,000.00 |
| Mar 31, 2026 | 274,000.00 |
| Dec 31, 2025 | 374,000.00 |
| Sep 30, 2025 | 399,000.00 |
| Jun 30, 2025 | 448,000.00 |
| Mar 31, 2025 | 390,000.00 |
| Dec 31, 2024 | 326,000.00 |
| Sep 30, 2024 | 256,000.00 |
| Jun 30, 2024 | 175,000.00 |
| Mar 31, 2024 | 245,000.00 |
| Dec 31, 2023 | 314,000.00 |
| Sep 30, 2023 | 369,000.00 |
| Jun 30, 2023 | 385,000.00 |
| Mar 31, 2023 | 369,000.00 |
| Dec 31, 2022 | 354,000.00 |
| Sep 30, 2022 | 334,000.00 |
| Jun 30, 2022 | 329,000.00 |
| Mar 31, 2022 | 325,000.00 |
| Dec 31, 2021 | 317,000.00 |
| Sep 30, 2021 | 305,000.00 |